David Younger, PhD

David is A-Alpha Bio’s founding CEO. He invented A-Alpha Bio’s AlphaSeq platform with Scientific Advisors David Baker and Eric Klavins at the University of Washington, where he received his PhD in Bioengineering. Prior to graduate school, David studied bioengineering and economics at Rice University and the London School of Economics. David’s technical expertise spans synthetic biology, protein engineering, and assay development. In his free time, David enjoys spending time with family and friends, woodworking, cycling, backpacking, climbing, and skiing in the Cascade Mountains.